|
1
|
Daley CA, Abbott A, Doyle PS, Nader GA and
Larson S: A review of fatty acid profiles and antioxidant content
in grass-fed and grain-fed beef. Nutr J. 9:102010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kris-Etherton PM, Harris WS, Appel LJ and
Nutrition Committee: Fish consumption, fish oil, omega-3 fatty
acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol.
23:e20–e30. 2003.PubMed/NCBI
|
|
3
|
Blasbalg TL, Hibbeln JR, Ramsden CE,
Majchrzak SF and Rawlings RR: Changes in consumption of omega-3 and
omega-6 fatty acids in the United States during the 20th century.
Am J Clin Nutr. 93:950–962. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bosma-den Boer MM, van Wetten ML and
Pruimboom L: Chronic inflammatory diseases are stimulated by
current lifestyle: How diet, stress levels and medication prevent
our body from recovering. Nutr Metab (Lond). 9:322012. View Article : Google Scholar
|
|
5
|
Engin AB, Tsatsakis AM, Tsoukalas D and
Engin A: Do flavanols-rich natural products relieve obesity-related
insulin resistance. Food Chem Toxicol. 112:157–167. 2018.
View Article : Google Scholar
|
|
6
|
Simopoulos AP and DiNicolantonio JJ: The
importance of a balanced ω-6 to ω-3 ratio in the prevention and
management of obesity. Open Heart. 3:e0003852016. View Article : Google Scholar
|
|
7
|
Patterson E, Wall R, Fitzgerald GF, Ross
RP and Stanton C: Health implications of high dietary omega-6
polyunsaturated Fatty acids. J Nutr Metab. 2012.539426:2012.
|
|
8
|
Liu Y, Song A, Yang X, Zhen Y, Chen W,
Yang L, Wang C and Ma H: Farnesoid X receptor agonist decreases
lipid accumulation by promoting hepatic fatty acid oxidation in
db/db mice. Int J Mol Med. 42:1723–1731. 2018.PubMed/NCBI
|
|
9
|
Feng L, Dou C, Wang J, Jiang C, Ma X and
Liu J: Upregulated 14 3 3β aggravates restenosis by promoting cell
migration following vascular injury in diabetic rats with elevated
levels of free fatty acids. Int J Mol Med. 42:1074–1085.
2018.PubMed/NCBI
|
|
10
|
Nathan C and Ding A: Nonresolving
inflammation. Cell. 140:871–882. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tabas I: Macrophage death and defective
inflammation resolution in atherosclerosis. Nat Rev Immunol.
10:36–46. 2010. View
Article : Google Scholar :
|
|
12
|
Chimenti MS, Triggianese P, Conigliaro P,
Candi E, Melino G and Perricone R: The interplay between
inflammation and metabolism in rheumatoid arthritis. Cell Death
Dis. 6:e18872015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Roxburgh CS and McMillan DC: Cancer and
systemic inflammation: Treat the tumour and treat the host. Br J
Cancer. 110:1409–1412. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Donath MY and Shoelson SE: Type 2 diabetes
as an inflammatory disease. Nat Rev Immunol. 11:98–107. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zafiropoulos A, Linardakis M, Jansen EHJM,
Tsatsakis AM, Kafatos A and Tzanakakis GN: Paraoxonase 1 R/Q
alleles are associated with differential accumulation of saturated
versus 20:5n3 fatty acid in human adipose tissue. J Lipid Res.
51:1991–2000. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nicholson JK: Global systems biology,
personalized medicine and molecular epidemiology. Mol Syst Biol.
2:522006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Karczewski KJ and Snyder MP: Integrative
omics for health and disease. Nat Rev Genet. 19:299–310. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wenk MR: The emerging field of lipidomics.
Nat Rev Drug Discov. 4:594–610. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao L, Ni Y, Ma X, Zhao A, Bao Y, Liu J,
Chen T, Xie G, Panee J, Su M, et al: A panel of free fatty acid
ratios to predict the development of metabolic abnormalities in
healthy obese individuals. Sci Rep. 6:284182016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Matthan NR, Ooi EM, Van Horn L, Neuhouser
ML, Woodman R and Lichtenstein AH: Plasma phospholipid fatty acid
biomarkers of dietary fat quality and endogenous metabolism predict
coronary heart disease risk: A nested case-control study within the
Women’s Health Initiative observational study. J Am Heart Assoc.
3:14–16. 2014. View Article : Google Scholar
|
|
21
|
Harris WS, Luo J, Pottala JV, Margolis KL,
Espeland MA and Robinson JG: Red blood cell fatty acids and
incident diabetes mellitus in the women’s health initiative memory
study. PLoS One. 11:e01478942016. View Article : Google Scholar
|
|
22
|
Shaw J: Fathoming metabolism. The study of
metabolites does an end run around genomics to provide telling
clues to your future health. Harv Mag. 3:27–31. 2011.
|
|
23
|
Wang TJ, Larson MG, Vasan RS, Cheng S,
Rhee EP, McCabe E, Lewis GD, Fox CS, Jacques PF, Fernandez C, et
al: Metabolite profiles and the risk of developing diabetes. Nat
Med. 17:448–453. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cheng S, Larson MG, Mccabe EL, Murabito
JM, Rhee EP, Ho JE, Jacques PF, Ghorbani A, Magnusson M, Souza AL,
et al: Distinct metabolomic signatures are associated with
longevity in humans. Nat Commun. 6:67912015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Clish CB: Metabolomics: An emerging but
powerful tool for precision medicine. Cold Spring Harb Mol Case
Stud. 1:a0005882015. View Article : Google Scholar
|
|
26
|
Stark KD, Van Elswyk ME, Higgins MR,
Weatherford CA and Salem N Jr: Global survey of the omega-3 fatty
acids, docosa-hexaenoic acid and eicosapentaenoic acid in the blood
stream of healthy adults. Prog Lipid Res. 63:132–152. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Abdelmagid SA, Clarke SE, Nielsen DE,
Badawi A, El-Sohemy A, Mutch DM and Ma DW: Comprehensive profiling
of plasma fatty acid concentrations in young healthy Canadian
adults. PLoS One. 10:e01161952015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Perreault M, Roke K, Badawi A, Nielsen DE,
Abdelmagid SA, El-Sohemy A, Ma DW and Mutch DM: Plasma levels of
14:0, 16:0, 16:1n-7, and 20:3n-6 are positively associated, but
18:0 and 18:2n-6 are inversely associated with markers of
inflammation in young healthy adults. Lipids. 49:255–263. 2014.
View Article : Google Scholar
|
|
29
|
Risé P, Eligini S, Ghezzi S, Colli S and
Galli C: Fatty acid composition of plasma, blood cells and whole
blood: Relevance for the assessment of the fatty acid status in
humans. Prostaglandins Leukot Essent Fatty Acids. 76:363–369. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kalogeropoulos N, Panagiotakos DB,
Pitsavos C, Chrysohoou C, Rousinou G, Toutouza M and Stefanadis C:
Unsaturated fatty acids are inversely associated and n-6/n-3 ratios
are positively related to inflammation and coagulation markers in
plasma of apparently healthy adults. Clin Chim Acta. 411:584–591.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Baum SJ: A survey of internists and
cardiologists: Are discoveries in fatty acids truly being
translated into clinical practice. Prostaglandins Leukot Essent
Fatty Acids. 88:3–4. 2013. View Article : Google Scholar
|
|
32
|
Hudita A, Galateanu B, Dinescu S, Costache
M, Dinischiotu A, Negrei C, Stan M, Tsatsakis A, Nikitovic D,
Lupuliasa D, et al: In vitro effects of cetylated fatty acids
mixture from celadrin on chondrogenesis and inflammation with
impact on osteoarthritis. Cartilage. May 1–2018.Epub ahead of
print. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Weylandt KH, Serini S, Chen YQ, Su HM, Lim
K, Cittadini A and Calviello G: Omega-3 polyunsaturated fatty
acids: The way forward in times of mixed evidence. Biomed Res Int.
2015.143109:2015.
|
|
34
|
Simopoulos AP: An increase in the
Omega-6/Omega-3 fatty acid ratio increases the risk for obesity.
Nutrients. 8:1282016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang YJ, Choi MH, Paik MJ, Yoon HR and
Chung BC: Gas chromatographic-mass spectrometric determination of
plasma saturated fatty acids using pentafluorophenyldimethylsilyl
derivatization. J Chromatogr B Biomed Sci Appl. 742:37–46. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ruiter AF, Ackermans MT and Endert E:
Simultaneous gas chromatographic determination of concentration and
isotopic enrichment of fatty acids in human plasma using flame
ionization and mass spectrometric detection. J Chromatogr B Biomed
Sci Appl. 759:169–174. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ecker J, Scherer M, Schmitz G and Liebisch
G: A rapid GC-MS method for quantification of positional and
geometric isomers of fatty acid methyl esters. J Chromatogr B
Analyt Technol Biomed Life Sci. 897:98–104. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tsoukalas D, Alegakis A, Fragkiadaki P,
Papakonstantinou E, Nikitovic D, Karataraki A, Nosyrev AE,
Papadakis EG, Spandidos DA, Drakoulis N, et al: Application of
metabolomics: Focus on the quantification of organic acids in
healthy adults. Int J Mol Med. 40:112–120. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Stellaard F, ten Brink HJ, Kok RM, van den
Heuvel L and Jakobs C: Stable isotope dilution analysis of very
long chain fatty acids in plasma, urine and amniotic fluid by
electron capture negative ion mass fragmentography. Clin Chim Acta.
192:133–144. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cheng S, Rhee EP, Larson MG, Lewis GD,
McCabe EL, Shen D, Palma MJ, Roberts LD, Dejam A, Souza AL, et al:
Metabolite profiling identifies pathways associated with metabolic
risk in humans. Circulation. 125:2222–2231. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Calder PC, Albers R, Antoine JM, Blum S,
Bourdet-Sicard R, Ferns GA, Folkerts G, Friedmann PS, Frost GS,
Guarner F, et al: Inflammatory disease processes and interactions
with nutrition. Br J Nutr. 101(Suppl 1): S1–S45. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Holmes E, Wilson ID and Nicholson JK:
Metabolic phenotyping in health and disease. Cell. 134:714–717.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Galli C and Calder PC: Effects of fat and
fatty acid intake on inflammatory and immune responses: A critical
review. Ann Nutr Metab. 55:123–139. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ferrucci L, Cherubini A, Bandinelli S,
Bartali B, Corsi A, Lauretani F, Martin A, Andres-Lacueva C, Senin
U and Guralnik JM: Relationship of plasma polyunsaturated fatty
acids to circulating inflammatory markers. J Clin Endocrinol Metab.
91:439–446. 2006. View Article : Google Scholar
|
|
45
|
Bersch-Ferreira ÂC, Sampaio GR, Gehringer
MO, Ross-Fernandes MB, Kovacs C, Alves R, Pereira JL, Magnoni CD,
Weber B and Rogero MM: Association between polyunsaturated fatty
acids and inflammatory markers in patients in secondary prevention
of cardiovascular disease. Nutrition. 37:30–36. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Harris WS, Del Gobbo L and Tintle NL: The
Omega-3 Index and relative risk for coronary heart disease
mortality: Estimation from 10 cohort studies. Atherosclerosis.
262:51–54. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Taghizadeh M, Tamtaji OR, Dadgostar E,
Daneshvar Kakhaki R, Bahmani F, Abolhassani J, Aarabi MH, Kouchaki
E, Memarzadeh MR and Asemi Z: The effects of omega-3 fatty acids
and vitamin E co-supplementation on clinical and metabolic status
in patients with Parkinson’s disease: A randomized, double-blind,
placebo-controlled trial. Neurochem Int. 108:183–189. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Simopoulos AP: The importance of the
omega-6/omega-3 fatty acid ratio in cardiovascular disease and
other chronic diseases. Exp Biol Med (Maywood). 233:674–688. 2008.
View Article : Google Scholar
|
|
49
|
Miles EA and Calder PC: Influence of
marine n-3 polyunsaturated fatty acids on immune function and a
systematic review of their effects on clinical outcomes in
rheumatoid arthritis. Br J Nutr. 107(Suppl 2): S171–S184. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Farvid MS, Ding M, Pan A, Sun Q, Chiuve
SE, Steffen LM, Willett WC and Hu FB: Dietary linoleic acid and
risk of coronary heart disease: A systematic review and
meta-analysis of prospective cohort studies. Circulation.
130:1568–1578. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Harris WS, Mozaffarian D, Rimm E,
Kris-Etherton P, Rudel LL, Appel LJ, Engler MM, Engler MB and Sacks
F: Omega-6 fatty acids and risk for cardiovascular disease: A
science advisory from the American Heart Association nutrition
subcommittee of the council on nutrition, physical activity, and
metabolism; council on cardiovascular nursing; and council on
epidem. Circulation. 119:902–907. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kohli P and Levy BD: Resolvins and
protectins: Mediating solutions to inflammation. Br J Pharmacol.
158:960–971. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yamashita K, Higa M, Kunishita R, Kanazawa
K, Tasaki M, Doi A, Yoshifuji A, Ichijo T, Ouchi H and Hirose T:
Ayumi Yoshifuji, Takamasa Ichijo, Hiromi Ouchi and Takahisa Hirose:
Dihomo-gamma-linolenic acid levels and obesity in patients with
type 2 diabetes. Diabetol Int. 6:206–211. 2015. View Article : Google Scholar
|
|
54
|
Kurotani K, Sato M, Ejima Y, Nanri A, Yi
S, Pham NM, Akter S, Poudel-Tandukar K, Kimura Y, Imaizumi K, et
al: High levels of stearic acid, palmitoleic acid, and
dihomo-γ-linolenic acid and low levels of linoleic acid in serum
cholesterol ester are associated with high insulin resistance. Nutr
Res. 32:669–675.e3. 2012. View Article : Google Scholar
|
|
55
|
Greene ER, Huang S, Serhan CN and
Panigrahy D: Regulation of inflammation in cancer by eicosanoids.
Prostaglandins Other Lipid Mediat. 96:27–36. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ito R, Satoh-Asahara N, Yamakage H, Sasaki
Y, Odori S, Kono S, Wada H, Suganami T, Ogawa Y, Hasegawa K, et al:
An increase in the EPA/AA ratio is associated with improved
arterial stiffness in obese patients with dyslipidemia. J
Atheroscler Thromb. 21:248–260. 2014. View Article : Google Scholar
|
|
57
|
Iwamatsu K, Abe S, Nishida H, Kageyama M,
Nasuno T, Sakuma M, Toyoda S and Inoue T: Which has the stronger
impact on coronary artery disease, eicosapentaenoic acid or
docosa-hexaenoic acid. Hypertens Res. 39:272–275. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wakabayashi Y, Funayama H, Ugata Y,
Taniguchi Y, Hoshino H, Ako J and Momomura S: Low eicosapentaenoic
acid to arachidonic acid ratio is associated with thin-cap
fibroatheroma determined by optical coherence tomography. J
Cardiol. 66:482–488. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Qian F, Korat AA, Malik V and Hu FB:
Metabolic effects of monounsaturated fatty acid-enriched diets
compared with carbohydrate or polyunsaturated fatty acid-enriched
diets in patients with type 2 diabetes: A systematic review and
meta-analysis of randomized controlled trials. Diabetes Care.
39:1448–1457. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Schwertner HA and Mosser EL: Comparison of
lipid fatty acids on a concentration basis vs weight percentage
basis in patients with and without coronary artery disease or
diabetes. Clin Chem. 39:659–663. 1993.PubMed/NCBI
|
|
61
|
Lagerstedt SA, Hinrichs DR, Batt SM,
Magera MJ, Rinaldo P and McConnell JP: Quantitative determination
of plasma c8-c26 total fatty acids for the biochemical diagnosis of
nutritional and metabolic disorders. Mol Genet Metab. 73:38–45.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Poobalan A and Aucott L: Obesity among
young adults in developing countries: A systematic overview. Curr
Obes Rep. 5:2–13. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Li K, Brennan L, McNulty BA, Bloomfield
JF, Duff DJ, Devlin NF, Gibney MJ, Flynn A, Walton J and Nugent AP:
Plasma fatty acid patterns reflect dietary habits and metabolic
health: A cross-sectional study. Mol Nutr Food Res. 60:2043–2052.
2016. View Article : Google Scholar : PubMed/NCBI
|
